SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
September 27, 2012
(Exact name of registrant as specified in
|(State of other jurisdiction
||(Commission File Number)
|14282 Franklin Avenue, Tustin, California 92780|
|(Address of Principal Executive Offices)|
|Registrant’s telephone number, including area code: (714) 508-6000|
|(Former name or former address, if changed since last report)|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other
On September 27, 2012,
Peregrine Pharmaceuticals, Inc. issued a press release announcing a change in the location of its 2012 Annual Meeting of Stockholders
to be held on October 18, 2012.
A copy of the press
release is attached to this Current Report on Form 8-K as Exhibit 99.1.
Item 9.01 Financial
Statements and Exhibits.
The following material is filed as an exhibit to this Current Report on Form 8-K:
Release issued September 27, 2012.
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
||PEREGRINE PHARMACEUTICALS, INC.|
|Date: September 27, 2012
||By: /s/ Paul J. Lytle|
||Paul J. Lytle|
||Chief Financial Officer|
||Press Release issued September 27, 2012|